CYP3A5 and ABCB1 genes and hypertension.

Détails

ID Serval
serval:BIB_4D26D0016704
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
CYP3A5 and ABCB1 genes and hypertension.
Périodique
Pharmacogenomics
Auteur⸱e⸱s
Bochud M., Bovet P., Burnier M., Eap C.B.
ISSN
1744-8042 (Electronic)
ISSN-L
1462-2416
Statut éditorial
Publié
Date de publication
2009
Peer-reviewed
Oui
Volume
10
Numéro
3
Pages
477-487
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Review
Publication Status: ppublish
Résumé
Hypertension is the first single modifiable cause of disease burden worldwide. Genes encoding proteins that are involved in the metabolism (CYP3A5) and transport (ABCB1) of drugs and hormones might contribute to blood pressure control in humans. Indeed, recent data have suggested that CYP3A5 and ABCB1 gene polymorphisms are associated with blood pressure in the rat as well as in humans. Interestingly, the effects of these genes on blood pressure appear to be modified by dietary salt intake. This review summarizes what is known regarding the relationships of the ABCB1 and CYP3A5 genes with blood pressure, and discusses the potential underlying mechanisms of the association. If the role of these genes in blood pressure control is confirmed in other populations and other ethnic groups, these findings would point toward a new pathway for blood pressure control in humans.
Mots-clé
Alternative Splicing/genetics, Blood Pressure/genetics, Blood Pressure/physiology, Cytochrome P-450 CYP3A/genetics, Cytochrome P-450 CYP3A/metabolism, Female, Genetic Variation, Homeostasis, Humans, Hypertension/enzymology, Hypertension/genetics, Introns, Male, P-Glycoprotein/genetics, RNA, Messenger/genetics
Pubmed
Web of science
Création de la notice
20/03/2009 10:01
Dernière modification de la notice
20/08/2019 15:01
Données d'usage